8831
Conditions
Interventions
Group 1: Control group with subcutaneous local anesthetic injection to treat puncture pain.
Group 2: Intervention group with cervical plexus block to treat puncture pain.
Sponsors
Diakonie Klinikum Jung-Stilling
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: ? Inpatient at the hospital ? Existing ability to provide information and give consent ? Ability to report pain intensity and location ? Indication for creating a ZVK ? Puncture and implantation site via the internal jugular vein (right or left)
Exclusion criteria
Exclusion criteria: ? Reciprocal statements of the inclusion criteria ? Patient's refusal to participate ? Richmond Agitation Sedation Score (RASS) no lower than -1 and no higher than +2 ? Sonographic control not technically feasible ? Known anatomical anomalies in the implantation and/or anesthetic area (e.g. surgery in the area of the right jugular vein, e.g. neck dissection) ? Infections in the implantation and/or anesthesia area ? Allergy to local anesthetics (medical history) ? Psychiatric illnesses that make it difficult for the patient to cooperate in the investment situation (clinical assessment) ? Existing acute, chronic or residual neurological symptoms involving the nerve structures of the cervical plexus (e.g. herniated disc, residual paralysis, polyneuropathy of the upper extremities) ? The patient has already taken part in a current study (e.g. in the case of re-CVC installation or CVC change) or is taking part in other studies
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Extent of the difference in the mean values ??of the pain reported by the intervention and control groups during the procedure on the Verbal Numerical Rating Scale (VNPRS). | — |
Secondary
| Measure | Time frame |
|---|---|
| a) Proportion of patients with severe pain (VNPRS >/= 6) compared to the control group. b) Difference in the frequencies of CVC-associated adverse effects in the intervention and control groups. c) Frequency of adverse effects of the cervical plexus blockade in the intervention group. | — |
Countries
Germany
Contacts
Public ContactArmin Seibel
Diakonie Klinikum Jung-Stilling
Outcome results
None listed